InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Tovey Christopher J., Chief Executive Officer. Officer active across 2 companies, notably GW Pharmaceuticals PLC. Cumulatively, 5 disclosures have been published. History available since 5 May 2021. The latest transaction was filed on 5 July 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Tovey Christopher J.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
4,032 shares@ US$0.020.0% of flowOrdinary SharesSEC:0001765581-22-000069:0
1,096 shares@ US$153.220.0011% mcap100.0% of flowOrdinary SharesSEC:0001765581-22-000043:0
7,820 shares0Ordinary SharesSEC:0001765581-22-000032:0
2,496 sharesOrdinary SharesSEC:0000899243-21-018673:0
9,091 shares0Ordinary SharesSEC:0001765581-21-000057:0
5 of 5 declarations
About Tovey Christopher J.
Christopher J. Tovey is the Chief Operating Officer and Executive Vice President at GW Pharmaceuticals PLC and Jazz Pharmaceuticals plc. In this role, he oversees the daily operations of the company and contributes to the overall strategy. His expertise in the pharmaceutical industry is an asset to both firms.
